This trade activity should not be overlooked: Bausch Health Companies Inc (BHC)

With 2.78 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.38 million shares. The 52-week range on BHC shows that it touched its highest point at $11.46 and its lowest point at $3.96 during that stretch. It currently has a 1-year price target of $8.80. Beta for the stock currently stands at 0.60.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BHC was up-trending over the past week, with a rise of 2.20%, but this was down by -12.50% over a month. Three-month performance dropped to -25.68% while six-month performance rose 13.61%. The stock lost -23.32% in the past year, while it has lost -19.23% so far this year. A look at the trailing 12-month EPS for BHC yields -0.48 with Next year EPS estimates of 5.03. For the next quarter, that number is 0.82. This implies an EPS growth rate of 7.28% for this year and 16.74% for next year. EPS is expected to grow by 11.08% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 32.76%.

Float and Shares Shorts:

At present, 365.24 million BHC shares are outstanding with a float of 290.88 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BHC since 4 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $4.00661 being high and $3.56478 being low. For BHC, this leads to a yearly average estimate of $3.74553. Based on analyst estimates, the high estimate for the next quarter is $1.14 and the low estimate is $0.97. The average estimate for the next quarter is thus $1.06.